APA (7th ed.) Citation

Maekawa, N., Konnai, S., Watari, K., Takeuchi, H., Nakanishi, T., Tachibana, T., . . . Ohashi, K. (2025). Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs. Frontiers in immunology, 16, 1570717. https://doi.org/10.3389/fimmu.2025.1570717

Chicago Style (17th ed.) Citation

Maekawa, Naoya, et al. "Development of Caninized Anti-CTLA-4 Antibody as Salvage Combination Therapy for Anti-PD-L1 Refractory Tumors in Dogs." Frontiers in Immunology 16 (2025): 1570717. https://doi.org/10.3389/fimmu.2025.1570717.

MLA (9th ed.) Citation

Maekawa, Naoya, et al. "Development of Caninized Anti-CTLA-4 Antibody as Salvage Combination Therapy for Anti-PD-L1 Refractory Tumors in Dogs." Frontiers in Immunology, vol. 16, 2025, p. 1570717, https://doi.org/10.3389/fimmu.2025.1570717.